Next-generation ctDNA-driven clinical trials in precision immuno-oncology

Saved in:
Bibliographic Details
Main Authors: Charu Aggarwal, Natasha B Leighl
Format: Article
Language:English
Published: BMJ Publishing Group 2023-01-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/11/1/e006397.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832582680764481536
author Charu Aggarwal
Natasha B Leighl
author_facet Charu Aggarwal
Natasha B Leighl
author_sort Charu Aggarwal
collection DOAJ
format Article
id doaj-art-5a8f551e427740278fdaa26da2ed59b6
institution Kabale University
issn 2051-1426
language English
publishDate 2023-01-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj-art-5a8f551e427740278fdaa26da2ed59b62025-01-29T11:35:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-01-0111110.1136/jitc-2022-006397Next-generation ctDNA-driven clinical trials in precision immuno-oncologyCharu Aggarwal0Natasha B Leighl12University of Pennsylvania School of Medicine, Philadelphia, PA, USADivision of Medical Oncology/Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canadahttps://jitc.bmj.com/content/11/1/e006397.full
spellingShingle Charu Aggarwal
Natasha B Leighl
Next-generation ctDNA-driven clinical trials in precision immuno-oncology
Journal for ImmunoTherapy of Cancer
title Next-generation ctDNA-driven clinical trials in precision immuno-oncology
title_full Next-generation ctDNA-driven clinical trials in precision immuno-oncology
title_fullStr Next-generation ctDNA-driven clinical trials in precision immuno-oncology
title_full_unstemmed Next-generation ctDNA-driven clinical trials in precision immuno-oncology
title_short Next-generation ctDNA-driven clinical trials in precision immuno-oncology
title_sort next generation ctdna driven clinical trials in precision immuno oncology
url https://jitc.bmj.com/content/11/1/e006397.full
work_keys_str_mv AT charuaggarwal nextgenerationctdnadrivenclinicaltrialsinprecisionimmunooncology
AT natashableighl nextgenerationctdnadrivenclinicaltrialsinprecisionimmunooncology